Mechanistic studies suggest that 2-OG activates HSCs to induce hepatic fibrosis by modulating MΦs through the GPR119/TAK1/NF-κB/TGF-β1 signaling pathway. The gene discussed is GPR119; the disease is Hepatic fibrosis.